Despite uncertainty and concern buffeting Massachusetts hospitals, the state’s largest health system saw its finances improve ...
Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...
The Trump administration intends to make its most forceful attempt yet at restricting gender-affirming care for transgender ...
It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...
BioMarin's new CEO had promised Wall Street there would be deals, and with Amicus, it has one the market likes.
The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...
Nine drugmakers are set to unveil deals with the Trump administration to lower the prices of some of their drugs, marking the ...
With its vaccine schedule, “Denmark has made a values choice to accept preventable hospitalizations and illnesses that other ...
The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.
The award is in response to an “unsolicited proposal,” according to documents in the Federal Register. The University of ...
UnitedHealth Group said Friday that the consultants it hired to audit its operations found they’re not only “robust,” but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results